Lentivirus Titer Determination. Speaker: Chi-long Lin May.,2008

Similar documents
PROTOCOL: OPTIMIZATION OF LENTIVIRAL TRANSDUCTION USING SPINFECTION

LentiBoost Lentiviral Transduction Enhancer

Large Scale Infection for Pooled Screens of shrna libraries

~Lentivirus production~

Constitutive Reporter Lentiviral Vectors Expressing Fluorescent Proteins

QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24)

QuickTiter Lentivirus Quantitation Kit (HIV p24 ELISA)

Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set

HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual)

Pre-made Reporter Lentivirus for MAPK/ERK Signal Pathway

Pre-made Reporter Lentivirus for JAK-STAT Signaling Pathway

Pre-made Lentiviral Particles for Fluorescent Proteins

Transfection of Sf9 cells with recombinant Bacmid DNA

Pre-made Reporter Lentivirus for NF-κB Signal Pathway

STAT3 (py705)/ Pan STAT3 (Human/Mouse/Rat) ELISA Kit

Human Immunodeficiency Virus type 1 (HIV-1) gp120 / Glycoprotein 120 ELISA Pair Set

Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set

TECHNICAL BULLETIN. Catalog Number RAB0447 Storage Temperature 20 C

Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set

Human Urokinase / PLAU / UPA ELISA Pair Set

Human LDL Receptor / LDLR ELISA Pair Set

Influenza B Hemagglutinin / HA ELISA Pair Set

2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit

Ready-to-use Lentiviral Particles for intracelular labeling

TECHNICAL BULLETIN. Phospho-Akt (pser 473 ) ELISA Kit for detection of human, mouse, or rat phospho-akt (pser 473 ) in cell and tissue lysates

RayBio Human Granzyme B ELISA Kit

Caspase-3 Assay Cat. No. 8228, 100 tests. Introduction

Procine sphingomyelin ELISA Kit

SOP History Number Date Reason for Change v1 10/10/2014 Original V2 10/10/2016 Update V3 10/10/2018 Update

Insulin Aspart ELISA Kit

Human Leptin ELISA Kit

NBP Protocol. Orders: Support: Web: NBP

Protease Assay. (Cat. # ) think proteins! think G-Biosciences

Human TSH ELISA Kit. User Manual

STAT1 (ps727) (Human/Mouse) ELISA Kit

RayBio Human Phosphotyrosine BTK ELISA Kit

Exendin-4 (Exenatide) ELISA Kit

QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24)

Influenza A H1N1 HA ELISA Pair Set

2-Deoxyglucose Assay Kit (Colorimetric)

Human Induced Plutipotent Stem Cell (ipsc) Handling Protocols: Matrigel and mtesr/e8 Media

Human LDL ELISA Kit. Innovative Research, Inc.

RayBio Human Phospho-DDR2 (Tyr740) and Total DDR2 ELISA Kit

Mouse C-Peptide ELISA Kit

BaculoELISA Titer Kit User Manual

HbA1c (Human) ELISA Kit

STAT3 (py705) (Human/Mouse/Rat) ELISA Kit

Rat cholesterol ELISA Kit

Human HBcAb IgM ELISA kit

H5N1 ( Avian Flu ) Hemagglutinin ELISA Pair Set

Lipoprotein Lipase Activity Assay Kit (Fluorometric)

EGFR (py1045)/ Pan EGFR (Human) ELISA Kit

Lumino Firefly Luciferase Assay

Chromatin Immunoprecipitation (ChIPs) Protocol (Mirmira Lab)

Exosome ELISA Complete Kits

Human ipsc-derived Ventricular Cardiomyocytes. Protocol version 3.1

RayBio Human, Mouse and Rat Phospho-NF-kB P65 (Ser536) and Total NF-kB P65 ELISA Kit

ab HIV-1 Protease Inhibitor Screening Kit (Fluorometric)

ab Prothrombin (Factor II) Human ELISA Kit

AssayMax Human Aldose Reductase ELISA Kit

ab Apolipoprotein A1 (APOA1) Human SimpleStep ELISA Kit

Human Alpha 1 microglobulin ELISA Kit

Human Cathepsin V ELISA Kit

Striatal Neuron Medium Kit

PFK Activity Assay Kit (Colorimetric)

Pre-made Lentiviral Particles for intracelular labeling: (LocLight TM Living cell imaging lentivirus for sub-cellular localization)

MyBioSource.com. QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24) Product Manual. Catalog Number. MBS x 96 assays

ab Hepatic Lipid Accumulation/ Steatosis Assay Kit

Exosome ELISA Complete Kits

ab Serum Amyloid P (APCS) Human ELISA Kit

Human ipsc-derived Microglial Precursors

CoQ10(Coenzyme Q10) ELISA Kit

RayBio Human ENA-78 ELISA Kit

Vitamin C Assay Kit. ( DNPH method )

Europium Labeling Kit

Note: During 30 minute incubation; proceed thru appropriate sections below (e.g. sections II, III and V).

Human Carbamylated LDL ELISA Kit (CBL-LDL Quantitation)

ab Apolipoprotein B (APOB) Human ELISA Kit

Human Thyroid-Peroxidase Antibody, TPO-Ab ELISA Kit

Prothrombin (Human) ELISA Kit

RayBio Human Phospho-DDR1 (Tyr792) ELISA Kit

ab Leptin Human ELISA Kit

Morinaga Mouse C-peptide ELISA Kit

RayBio Human Phospho-DDR1 (Tyr792) and Total DDR1 ELISA Kit

SensoLyte 520 Cathepsin K Assay Kit *Fluorimetric*

Rat Mullerian Inhibiting Substance/Anti-Mullerian hormone, MIS/AMH ELISA kit

Rat C-peptide ELISA. For the quantitative determination of C-peptide in rat serum

SensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric*

Human Oxidized LDL ELISA Kit (MDA-LDL Quantitation), General

SensoLyte Rh110 Cathepsin K Assay Kit *Fluorimetric* Revision#1.2 Last Updated: May 2017 Catalog # Kit Size

O. Repeat the measurement in all relevant modes used in your experiments (e.g. settings for orbital averaging).

ab Cathepsin D Human ELISA Kit

Human HIV (1+2) antigen&antibody ELISA Kit

Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

ab Human Cathepsin D SimpleStep ELISA Kit

Human Cathepsin V ELISA Kit

ab Human Citrate Synthase (CS) Activity Assay Kit

Transcription:

Lentivirus Titer Determination Speaker: Chi-long Lin May.,2008

Why do we need to get virus titer?

RNAi knockdown vs. Viral dose Incomplete infection Ideal RNAi KD effect Cytotoxicity / Off target 0 X Y Added Virus volume

Lentiviral stock titration- Protocol Seeding cell Virus infection / transduction Serial diluted virus incubate with cells (mix with polybrene and Spin) Proper Antibiotic selection (optional) Virus titer (TU/ml) determination

Optimization of lentiviral transduction Lentiviral transduction should be optimized for each cell line and cell-based assay. Parameters needed to be test before starting infections to determine the optimal conditions for a given experiment Cell seeding density Antibiotic concentration Time-course course

Optimize transduction method -Cell seeding density/ Time-course 7000 D=5000 D=7500 7000 D=5000 D=7500 6000 D=10000 6000 D=10000 L u c ife ra se inte nsity 5000 4000 3000 2000 1000 Luciferase inte nsity 5000 4000 3000 2000 1000 0 0 shluc 224 shluc 221 pgk-gfp noinfection shluc 224 shluc 221 pgk-gfp noinfection 4 days (post-infection) 6 days (post-infection)

Optimize transduction method - Use of polybrene to enhance transduction Polybrene (hexadimethrine( bromide) mediated transduction of lentivirus can enhance transduction efficiency Determine experimental cell s s sensitivity to polybrene. (range from 0-100 ug/ml) Protamine sulfate could be an alternative to enhance transduction efficiency. Howard et al (2004). Biophysical Journal 86: 1234 42. 42.

Optimize transduction method Perform spin infection or just leave overnight without spin Spin infection condition: Speed : 1170g Time : 30 ~90 min. at 37 or RT Remove virus immediately after spin and replace with fresh medium

Optimize transduction method - Spin infection A549 cell, 1170g, 37 0 C Polybrene:working concentration 8μg/ml 8

Optimize transduction method - Spin-infection infection vs. non-spin infection 14000 12000 10000 CTR01 AAK93 RFU 8000 6000 4000 2000 0 37 oc Spin 0.5h RT shaker 1h 37 oc shaker 1h A549 cell Polybrene:working concentration 8μg/ml 8

Optimize transduction method -Antibiotic () concentration A549 Cell survival absorbance versus puro conc. Absorbance (485 nm) 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 Puromycin concentration (ug/ml) 50 h 48 h 44 h 40 h

Virus stock titration- Methods Relative virus titer determination Relative infection unit (RIU)/ml Puromycin selection / cell viability assay. Cell survival % 90 80 70 60 50 40 30 20 10 0 Standard Curve y = 211.73x + 17.041 R 2 = 0.996 0 0.1 0.2 0.3 0.4 Virus volume (ul) End point dilution or limiting dilution method Colony formation unit (CFU)/ml Puromycin selection / colonies counting GFP expressed detection Transduction Unit/ml or TU/ml FACS analysis

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 1170g 30 min. at 37 then return to incubator 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer Mock

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer

Relative virus titer determination Day 1 Day 2 Day 3 Day 5 Seed A549 cells 6000/well at 96 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media containing 48 hours after addition: Remove media; replace with phenol red free media containing 10% MTS. After 40-50 minutes incubation, record the absorbance at 490 nm using plate reader. Define the liner range to determine the relative titer

Relative virus titer determination

End point dilution or limiting Day 1 Day 2 Day 3 Day 4 dilution method Seed A549 cells 2X10 5 /well at 6 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media without 48 hours after virus addition: Change media with culture media containing Day 5-14 Replace medium with fresh medium containing every 3 4 days. Day 14 Remove the medium and gently wash each well with 3ml PBS once. Add 1 ml crystal violet solution and incubate 10 minutes at room temperature.

End point dilution or limiting Day 1 dilution method Seed A549 cells 2X10 5 /well at 6 well plate Day 2 Day 3 Day 4 Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media without 48 hours after virus addition: Change media with culture media containing 2 ml 10-fold serial dilutions ranging from 10-2 to 10-6 in 15 ml conical vials. Mix gently by inverting the tubes 10 times. Day 5-14 Replace medium with fresh medium containing every 3 4 days. Day 14 Remove the medium and gently wash each well with 3ml PBS once. Add 1 ml crystal violet solution and incubate 10 minutes at room temperature.

End point dilution or limiting Day 1 dilution method Seed A549 cells 2X10 5 /well at 6 well plate Day 2 Day 3 Day 4 Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media without 48 hours after virus addition: Change media with culture media containing Add 1 ml culture medium containing polybrene to one well as a mock control. Add 1ml of each of diluted virus to the remaining wells of the plate. Day 5-14 Replace medium with fresh medium containing every 3 4 days. Day 14 Remove the medium and gently wash each well with 3ml PBS once. Add 1 ml crystal violet solution and incubate 10 minutes at room temperature.

End point dilution or limiting dilution method Day 1 Day 2 Day 3 Day 4 Seed A549 cells 2X10 5 /well at 6 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media without 48 hours after virus addition: Change media with culture media containing Day 5-14 Replace medium with fresh medium containing every 3 4 days. Day 14 Remove the medium and gently wash each well with 3ml PBS once. Add 1 ml crystal violet solution and incubate 10 minutes at room temperature. Count the blue-stained colonies.

End point dilution or limiting dilution method Day 1 Day 2 Day 3 Day 4 Seed A549 cells 2X10 5 /well at 6 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media without 48 hours after virus addition: Change media with culture media containing Day 5-14 Replace medium with fresh medium containing every 3 4 days. Day 14 Remove the medium and gently wash each well with 3ml PBS once. Add 1 ml crystal violet solution and incubate 10 minutes at room temperature. Count the blue-stained colonies.

End point dilution or limiting dilution method Day 1 Day 2 Day 3 Day 4 Seed A549 cells 2X10 5 /well at 6 well plate Prepare virus dilutions Add diluted virus to cells in media containing polybrene Centrifuge cells 24 hours after virus addition: Change media with culture media without 48 hours after virus addition: Change media with culture media containing Day 5-14 Replace medium with fresh medium containing every 3 4 days. Day 14 Remove the medium and gently wash each well with 3ml PBS once. Add 1 ml crystal violet solution and incubate 10 minutes at room temperature. Count the blue-stained colonies.

End point dilution or limiting dilution method

Critical Factors Affecting Virus Titer Storage time for lentivirus stock. -80 C, > 6 months re-titration Number of freeze/thaw cycles. Virus titer decreases by 5-10% 5 with each freeze/thaw cycle Storage condition of lentivirus stock. Aliquot & store at -80 C C temperature

How to Convert Virus Titer on different cell lines TU N =TU O (TUR TUS) TU N = 換算後, 相對在實驗細胞株之 Lentivirus-X 的 RIU TU O = 利用 A549 細胞測量之 Lentivirus-X RIU ( 由 RNAi Core 提供 ) TU R = 利用實驗細胞株測量所得的標準病毒的 RIU TU S = 利用 A549 細胞測量所得的的標準病毒的 RIU ( 由 RNAi Core 提供 )

How to Convert Virus Titer on different cell lines A549 Cell survival % 100 90 80 70 60 50 40 30 20 10 0 Standard Curve 0 0.2 0.4 0.6 0.8 1 1.2 Virus volume (ul) Cell survival % 90 80 70 60 50 40 30 20 10 0 Standard Curve y = 211.73x + 17.041 R 2 = 0.996 0 0.1 0.2 0.3 0.4 Virus volume (ul) shluc virus 1x10 4 RIU/ul Lentivirus X1 Xn 3x10 4 9x10 3 RIU/ul S Cell survival % 160 140 120 100 80 60 40 20 0 Standard Curve 0 4 8 12 16 20 24 28 32 36 Cell survival percentage 100 80 60 40 20 0 Standard Curve y = 18.58x + 15.545 R 2 = 0.9906 0 1 2 3 4 5 shluc virus 1x10 3 RIU/ul Lentivirus Xn? RIU/ul Virus volume (ul) Virus volume (ul)

How to Convert Viruses Titer on different cell lines TU N =TU O (TUR TUS) 3x10 3 3x10 4 1x10 3 1x10 4 TU N = 換算後, 相對在 S 細胞之 Lentivirus-X1 的 RIU TU O = 利用 A549 細胞測量之 Lentivirus-X1 的 RIU ( 由 RNAi Core 提供 ) 3x10 4 RIU/ul TU R = 利用 S 細胞株測量所得的標準病毒的 RIU 1x10 3 RIU/ul TU S = 利用 A549 細胞測量所得的的標準病毒的 RIU ( 由 RNAi Core 提供 ) 1x10 4 RIU/ul

Thank You

Protamine sulfate Protamine sulfate is a small cationic protein that binds and precipitates DNA. It may be used for the removal of DNA from protein samples or the purification of DNA binding proteins. Protamine sulfate may also be used as an alternative to polybrene in retroviral mediated gene transfer. Protamine sulfate is a drug that reverses the anticoagulant effects of heparin by binding to it. Protamine was formerly isolated from the sperm of various fish, but is now produced through recombinant biotechnology. It is a highly cationic peptide. It binds to heparin to form a stable ion pair which does not have anticoagulant activity. This complex is then removed and broken down by the reticuloendothelial system. Cornetta, K., and Anderson, W. F., Protamine Sulfate as an Effective Alternative to Polybrene in Retroviral-mediated Gene-transfer: Implications for Human Gene Therapy. J. Virol. Methods, 23(2),187-194 (1989).

Polybrene Polybrene (hexadimethrine bromide) is a cationic polymer used to increase the efficiency of infection of certain cells with a retrovirus in cell culture. Polybrene acts by neutralizing the charge repulsion between the virions and cell surface. It has other uses, including a role in protein sequencing. Howard E. Davis, Matthew Rosinski, Jeffrey R. Morgan and Martin L. Yarmush, et al (2004). "Charged Polymers Modulate Retrovirus Transduction via Membrane Charge Neutralization and Virus Aggregation.". Biophysical Journal 86: : 1234 42. 42.